SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 32 filers reported holding SINOVAC BIOTECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,845 | 0.0% | 9,095 | 0.0% | 0.00% | – |
| Q2 2023 | $58,845 | +320.3% | 9,095 | +334.1% | 0.00% | – |
| Q3 2022 | $14,000 | -76.3% | 2,095 | -77.0% | 0.00% | – |
| Q2 2022 | $59,000 | 0.0% | 9,095 | 0.0% | 0.00% | – |
| Q4 2021 | $59,000 | 0.0% | 9,095 | 0.0% | 0.00% | – |
| Q3 2021 | $59,000 | 0.0% | 9,095 | 0.0% | 0.00% | – |
| Q2 2021 | $59,000 | – | 9,095 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 9,095 | 0.0% | 0.00% | – |
| Q4 2020 | $58,000 | -1.7% | 9,095 | 0.0% | 0.00% | – |
| Q3 2020 | $59,000 | 0.0% | 9,095 | 0.0% | 0.00% | – |
| Q2 2020 | $59,000 | +7.3% | 9,095 | +6.3% | 0.00% | – |
| Q1 2020 | $55,000 | 0.0% | 8,557 | 0.0% | 0.00% | – |
| Q4 2019 | $55,000 | – | 8,557 | +30.5% | 0.00% | – |
| Q3 2019 | $0 | – | 6,557 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 6,557 | 0.0% | 0.00% | – |
| Q1 2019 | $42,000 | +20.0% | 6,557 | +30.5% | 0.00% | – |
| Q4 2018 | $35,000 | -7.9% | 5,026 | 0.0% | 0.00% | – |
| Q3 2018 | $38,000 | -9.5% | 5,026 | -11.2% | 0.00% | – |
| Q2 2018 | $42,000 | -36.4% | 5,657 | -25.7% | 0.00% | – |
| Q1 2018 | $66,000 | +371.4% | 7,616 | +271.9% | 0.00% | – |
| Q3 2017 | $14,000 | +100.0% | 2,048 | +104.8% | 0.00% | – |
| Q2 2017 | $7,000 | +16.7% | 1,000 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | -45.5% | 1,000 | -44.0% | 0.00% | – |
| Q4 2016 | $11,000 | +83.3% | 1,786 | +78.6% | 0.00% | – |
| Q3 2016 | $6,000 | +500.0% | 1,000 | +843.4% | 0.00% | – |
| Q2 2016 | $1,000 | -96.8% | 106 | -98.0% | 0.00% | – |
| Q4 2015 | $31,000 | +14.8% | 5,389 | 0.0% | 0.00% | – |
| Q3 2015 | $27,000 | -6.9% | 5,389 | -2.2% | 0.00% | – |
| Q2 2015 | $29,000 | -23.7% | 5,511 | -27.7% | 0.00% | – |
| Q1 2015 | $38,000 | -19.1% | 7,626 | -15.9% | 0.00% | – |
| Q4 2014 | $47,000 | – | 9,065 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |